Stocks
Heron Therapeutics (HRTX) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -215.3 | -176.7 | -103.8 | -5.06 | -17.9 | -20.6 | ||
| Changes by years, y/y, % | -3% | -18% | -41% | -95% | +254% | -39.6% | |||
Heron Therapeutics. EBITDA US GAAP, bln rub
Heron Therapeutics. EBITDA US GAAP, changes, %
Heron Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Heron Therapeutics (HRTX) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 3.71 | -1.03 | -14.0 | -0.792 | -4.77 | -20.6 | |
| Changes by years, y/y, % | -190% | -82% | +261% | -109% | -229% | |||
| Changes by quarters, q/q, % | -58% | -128% | +1 263% | -94% | +502% | |||
